Proposal of an in silico profiler for categorisation of repeat dose toxicity data of hair dyes

Archives of Toxicology

Volumn 89, Issue 5, 2015, Pages 733-741

  Nelms, M D ^a   Ates, G ^b   Madden, J C ^a   Vinken, M ^b   Cronin, M T D ^a   Rogiers, V ^b   Enoch, S J ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

AOP; Hair dyes; Mitochondrial toxicity; Repeat dose toxicity; Structural alerts

Indexed keywords

HAIR DYE;

BIOLOGICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DRUG EFFECTS; HUMAN; MITOCHONDRION; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION;

COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HAIR DYES; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84939887240     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1277-8     Document Type: Article

References (46)

1. Amacher DE (2005) Drug-associated mitochondrial toxicity and its detection. Curr Med Chem 12:1829–1839
2. Ankley GT, Bennett RS, Erickson RJ et al (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29(3):730–741
3. Aptula AO, Enoch SJ, Roberts DW (2009) Chemical mechanisms for skin sensitisation by aromatic compounds with hydroxy and amino groups. Chem Res Toxicol 22:1541–1547
4. Bironaite DA, Cenas NK, Kulys J (1991) The rotenone-insensitive reduction of quinones and nitrocompounds by mitochondrial NADH: ubiquinone reductase. Biochem et Biophys Acta 1060:203–209
5. Chan K, Truong D, Shangari N, O’Brien PJ (2005) Drug-induced mitochondrial toxicity. Expert Opin Drug Metab Toxicol 1:655–669
6. Dykens JA, Will Y (2007) The significance of mitochondrial toxicity testing in drug development. Drug Discovery Today 12:777–785
7. Dykens JA, Will Y (2008) Drug-induced mitochondrial dysfunction. Wiley-Interscience, New Jersey
8. EC (2003) Directive 2003/15/EC (Cosmetics Directive) Official Journal of the European Union
9. EC (2007) REACH technical guidance (located at http://ecb.jrc.it/reach/rip/)
10. Enoch SJ, Roberts DW (2013) Approaches for grouping chemicals into categories. In: Cronin MTD, Madden JC, Enoch SJ, Roberts DW (eds) Chemical toxicity prediction: category formation and read-across. The Royal Society of Chemistry, Cambridge, pp 30–43
11. Enoch SJ, Cronin MTD, Schultz TW, Madden JC (2008) Quantitative and mechanistic read across for predicting the skin sensitisation potential of alkenes acting via Michael addition. Chem Res Toxicol 21:513–520
12. Enoch SJ, Cronin MTD, Ellison CM (2011a) The use of a chemistry based profiler for covalent DNA binding in the development of chemical categories for read-across for genotoxicity. Altern Lab Anim 39:131–145
13. Enoch SJ, Ellison CM, Schultz TW, Cronin MTD (2011b) A review of the electrophilic reaction chemistry involved in covalent protein binding relevant to toxicity. Crit Rev Toxicol 41:783–802
14. Enoch SJ, Cronin MTD, Schultz TW (2012a) The definition of the applicability domain relevant to skin sensitisation for the aromatic nucleophilic substitution electrophilic mechanism. SAR QSAR Environ Res 23:649–663
15. Enoch SJ, Seed MJ, Roberts DW, Cronin MTD, Stocks SJ, Agius RM (2012b) Development of mechanism-based structural alerts for respiratory sensitisation hazard identification. Chem Res Toxicol 25:2490–2498
16. NAr reaction for substituted pyridines and pyrimidines. SAR QSAR Environ Res 24:385–392
17. Enoch SJ, Przybylak KP, Cronin MTD (2013b) Category formation case studies. In: Cronin MTD, Madden JC, Enoch SJ, Roberts DW (eds) Chemical toxicity prediction: category formation and read-across, vol 17. RSC, Cambridge
18. Gago-Dominguez M, Castelao JE, Yuan J, Yu MC, Ross RK (2001) Use of permanent hair dyes and bladder cancer risk. Int J Cancer 91:575–579
19. Gorontzy T, Kuver J, Blotevogel K (1993) Microbial transformation of nitroaromatic compounds under anaerobic conditions. J Gen Microbiol 139:1331–1336
20. Gutsell S, Russell P (2013) The role of chemistry in developing understanding of adverse outcome pathways and their application in risk assessment. Toxicol Res 2:299–307
21. Henry TR, Wallace KB (1995) Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol Appl Pharmacol 134:195–203
22. Hewitt M, Enoch SJ, Madden JC, Przybylak KP, Cronin MTD (2013) Hepatotoxicity: a scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action. Crit Rev Toxicol 43(7):537–558
23. Kalgutkar AS, Gardner I, Obach RS et al (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:161–225
24. Kappus H (1986) Overview of enzyme systems involved in bio-reduction of drugs and in redox cycling. Biochem Pharmacol 335:1–6
25. Kitani A, So Y, Miller LL (1981) An electrochemical study of the kinetics of NADH being oxidised by diimines derived from diaminobenzenes and diaminopyrimidines. J Am Chem Soc 103:7636–7641
26. Kovacic P, Jacintho JD (2001a) Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 8:773–796
27. Kovacic P, Jacintho JD (2001b) Reproductive toxins: pervasive theme of oxidative stress and electron transfer. Curr Med Chem 8:863–892
28. Montaigne D, Hurt C, Neviere R (2012) Mitochondria death/survival signalling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int 2012:ID 951539
29. Munday R (1992) Mitochondrial oxidation of p-phenylenediamine derivatives in vitro: structure-activity relationships and correlation with myotoxic activity in vivo. Chem Biol Interact 82:165–179
30. Nam S, Renganathan V (2000) Non-enzymatic reduction of azo dyes by NADH. Chemosphere 40:351–357
31. Naven RT, Swiss R, Klug-Mcleod J, Will Y, Greene N (2013) The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation. Toxicol Sci 131(1):271–278
32. Nelms MD, Cronin MTD, Schultz TW, Enoch SJ (2013) Experimental verification, and domain definition, of structural alerts for protein binding: epoxides, lactones, nitroso, nitros, aldehydes and ketones. SAR QSAR Environ Res 24:695–709
33. Nikam A, Patankar JV, Lackner C et al (2013) Transition between acute and chronic hepatotoxicity in mice is associated with impaired energy metabolism and induction of mitochondrial heme oxygenase-1. PLoS ONE 8:e66094
34. Ohkuma Y, Hiraku Y, Kawanishi S (2001) Sequence-specific DNA damage induced by carcinogenic danthron and anthraquinone in the presence of Cu(II), cytochrome P450 reductase and NADPH. Free Radical Res 34:595–604
35. Pessayre D, Fromenty B, Berson A et al (2012) Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 44:34–87
36. Porceddu M, Buron N, Roussel C, Labbe G, Fromenty B, Borgne-Sanchez A (2012) Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol Sci 129:332–345
37. Przybylak KR, Schultz TW (2013) Informing chemical categories through the development of adverse outcome pathways. In: Cronin MTD, Madden JC, Enoch SJ, Roberts DW (eds) Chemical toxicity prediction: category formation and read-across, vol 17. RSC, Cambridge, pp 44–71
38. Rodriguez-Sanchez N, Schultz TW, Cronin MTD, Enoch SJ (2013) Experimental verification of structural alerts for the protein binding of cyclic compounds acting as Michael acceptors. SAR QSAR Environ Res 24:963–977
39. Roldan MD, Perez-Reinado E, Castillo F, Moreno-Vivian C (2008) Reduction of polynitroaromatic compounds: the bacterial nitroreductases. Microbiol Rev 32:474–500
40. Sakuratani Y, Zhang HQ, Nishikawa S et al (2013a) Hazard evaluation support system (HESS) for predicting repeated dose toxicity using toxicological categories. SAR QSAR Environ Res 24:351–363
41. Sakuratani Y, Zhang HQ, Nishikawa S et al (2013b) Categorization of nitrobenzenes for repeated dose toxicity based on adverse outcome pathways. SAR QSAR Environ Res 24:35–46
42. Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B (2007) The role of mitochondria in pharmacotoxicology: a re-evaluation of an old, newly emerging topic. Am J Physiol Cell Physiol 293:C12–C21
43. Terada H (1990) Uncouplers of oxidative phosphorylation. Environ Health Perspect 87:213–218
44. Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158–165
45. Vinken M, Whelan M, Rogiers V (2013) Adverse outcome pathways: hype or hope? Arch Toxicol (Guest editorial)
46. Wallace KB, Starkov AA (2000) Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol 40:353–388